Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients
T.M. Scherzer, A.F. Stattermayer, R. Stauber, A. Maieron, M. Strasser, and H. Laferl et al. Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients J Hepatol 59 2013 964 971
E. Brochot, C. Francois, S. Castelain, F. Helle, A.N. Van Nhien, and I. Duchaussoy et al. A new tool to study ribavirin-induced haemolysis Antivir Ther 17 2012 1311 1317
Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy
Y. Inoue, M. Homma, Y. Matsuzaki, M. Shibata, T. Matsumura, and T. Ito et al. Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy Hepatol Res 34 2006 23 27
Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons
Y. Yamada, H. Sekihara, M. Omura, T. Yanase, R. Takayanagi, and T. Mune et al. Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons Endocr J 54 2007 153 162
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage
L. De Franceschi, G. Fattovich, F. Turrini, K. Ayi, C. Brugnara, and F. Manzato et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage Hepatology 31 2000 997 1004
Anemia management in the era of triple combination therapy for chronic HCV
I.M. Jacobson, K.V. Kowdley, and P.Y. Kwo Anemia management in the era of triple combination therapy for chronic HCV Gastroenterol Hepatol (N Y) 8 2012 1 16
Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease
C. Piketty, D. Jayle, A. Leplege, P. Castiel, E. Ecosse, and G. Gonzalez-Canali et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease Clin Endocrinol (Oxf) 55 2001 325 330